SARS‐CoV‐2 infections in cancer outpatients—Most infected patients are asymptomatic carriers without impact on chemotherapy

Oncologic patients are regarded as the population most at risk of developing a severe course of COVID‐19 due to the fact that malignant diseases and chemotherapy often weaken the immune system. In the face of the ongoing SARS‐CoV‐2 pandemic, how particular patients deal with this infection remains a...

Descripción completa

Detalles Bibliográficos
Autores principales: Hempel, Louisa, Piehler, Armin, Pfaffl, Michael W., Molnar, Jakob, Kirchner, Benedikt, Robert, Sebastian, Veloso, Julia, Gandorfer, Beate, Trepotec, Zeljka, Mederle, Stefanie, Keim, Sabine, Milani, Valeria, Ebner, Florian, Schweneker, Katrin, Fleischmann, Bastian, Kleespies, Axel, Scheiber, Josef, Hempel, Dirk, Zehn, Dietmar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7643635/
https://www.ncbi.nlm.nih.gov/pubmed/33022856
http://dx.doi.org/10.1002/cam4.3435

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7643635/
https://www.ncbi.nlm.nih.gov/pubmed/33022856
http://dx.doi.org/10.1002/cam4.3435

Ejemplares similares